FIELD: organic chemistry, medicine, pharmacology, biochemistry.
SUBSTANCE: invention relates to using IκB kinase inhibitors of the formula (Ia): 
for preparing drugs used in treatment pains and possessing the enhanced effectiveness.
EFFECT: valuable medicinal properties of substances.
5 cl, 7 tbl, 1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| DERIVATIVES OF BICYCLIC IMINOACIDS AS MATRIX METALLOPROTEINASE INHIBITORS | 2004 |
|
RU2335494C2 |
| NOVEL DERIVATIVES OF IMIDAZOLIDINE, THEIR PREPARING, THEIR APPLICATION AND PHARMACEUTICAL PREPARATIONS CONTAINING THEREOF | 1998 |
|
RU2213737C2 |
| UREA AND SULPHAMIDE DERIVATIVES AS TAFIA INHIBITORS | 2007 |
|
RU2459619C2 |
| N-ARYLSULFONYL AMINO ACID OMEGA-AMIDES | 1999 |
|
RU2228330C2 |
| SUBSTITUTED INDOLES | 2000 |
|
RU2255087C2 |
| SUBSTITUTED BENZIMIDAZOLES AND MEDICINAL AGENT BASED ON THEREOF | 2000 |
|
RU2261248C2 |
| IMIDAZOLE DERIVATIVES AS TAFIa INHIBITORS | 2005 |
|
RU2375356C2 |
| SULFONYLAMINOCARBOXYLIC ACIDS | 1998 |
|
RU2193027C2 |
| SUBSTITUTED DIAMINOCARBOXYLIC ACIDS | 1998 |
|
RU2196768C2 |
| NEW FIVE-MEMBER HETEROCYCLES, THEIR PREPARING, THEIR APPLYING AND PHARMACEUTICAL PREPARATIONS COMPRISING THEREOF | 1998 |
|
RU2240326C2 |
